Search Within

Mark Andrew Dickson

  1. "Sarcoma Surgeons"
Formats
  1. Journal Article (31)
  2. Meeting Abstract (24)
Groups
  1. Department of Medicine (55)
  2. Sarcoma Service (55)
  3. Sarcoma Surgeons (55)
  4. Solid Tumor Oncology Division (55)
  5. Surgery (55)
  6. GSK Faculty (54)

More Groups

People
  1. Samuel Singer (51)
  2. William Tap (49)
  3. Mary Keohan (41)
  4. Sandra D'Angelo (40)
  5. Mrinal Gounder (39)
  6. Cristina Antonescu (38)

More People

Years
  1. 2024 (6)
  2. 2023 (4)
  3. 2022 (11)
  4. 2021 (3)
  5. 2020 (4)
  6. 2019 (4)

More Years

Publications
  1. Journal of Clinical Oncology (18)
  2. Clinical Cancer Research (9)
  3. Annals of Oncology (5)
  4. Nature Communications (4)
  5. JAMA Oncology (2)
  6. Modern Pathology (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (19)
  2. American Association for Cancer Research (10)
  3. Oxford University Press (7)
  4. Nature Publishing Group (6)
  5. American Medical Association (2)
  6. Elsevier Inc. (2)

More Publishers

Results (55)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I study of binimetinib (MEK162) combined with pexidartinib (PLX3397) in patients with advanced gastrointestinal stromal tumor
    Journal Article

    Rosenbaum, E.; Kelly, C.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M.; Keohan, M. L.; Movva, S.; Condy, M.; Adamson, T.; Mcfadyen, C. R.; more...
    The Oncologist (2019)

    Fulltext@MSK | Save
  • A phase Ib study of BGJ398, a pan-FGFR kinase inhibitor in combination with imatinib in patients with advanced gastrointestinal stromal tumor
    Journal Article

    Kelly, C. M.; Shoushtari, A. N.; Qin, L. X.; D’Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Mcfadyen, C.; Sjoberg, A.; Singer, S.; more...
    Investigational New Drugs (2019)

    Fulltext@MSK | Save
  • A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with metastatic sarcoma
    Meeting Abstract

    Kelly, C. M.; Bowler, T. G.; Munhoz, R. R.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Dholakia, R.; Condy, M. M.; Singer, S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • PDLIM7 and CDH18 regulate the turnover of MDM2 during CDK4/6 inhibitor therapy-induced senescence
    Journal Article

    Klein, M. E.; Dickson, M. A.; Antonescu, C.; Qin, L. X.; Dooley, S. J.; Barlas, A.; Manova, K.; Schwartz, G. K.; Crago, A. M.; Singer, S.; more...
    Oncogene (2018)

    Fulltext@MSK | Save
  • Senescence after growth arrest: A mechanism by which CDK4/6 inhibitors can mediate their activity suppressing tumor progression
    Meeting Abstract

    Koff, A.; Klein, M. E.; Dickson, M. A.; Antonescu, C.; Qin, L. X.; Dooley, S. J.; Schwartz, G.; Crago, A. M.; Singer, S.; Tap, W. D.
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • CDK4 inhibition and senescence: Pathway understanding leads to rational drug combinations
    Meeting Abstract

    Klein, M. E.; Kovatcheva, M.; Dickson, M. A.; Liu, D.; Crago, A. M.; Schwartz, G. K.; Tap, W. D.; Singer, S.; Koff, A.
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • The clinical impact of performing routine next generation sequencing (NGS) in gastrointestinal stromal tumors (GIST)
    Meeting Abstract

    Kelly, C. M.; Bowler, T. G.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Vonya, T.; Yoon, S. S.; Singer, S.; DeMatteo, R. P.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • ATRX is a regulator of therapy induced senescence in human cells
    Journal Article

    Kovatcheva, M.; Liao, W.; Klein, M. E.; Robine, N.; Geiger, H.; Crago, A. M.; Dickson, M. A.; Tap, W. D.; Singer, S.; Koff, A.
    Nature Communications (2017)

    Fulltext@MSK | Save
  • Efficacy of sorafenib in patients with desmoid-type fibromatosis
    Meeting Abstract

    Munhor, R. R.; Lefkowitz, R. A.; Kuk, D.; Dickson, M. A.; D'Angelo, S. P.; Keohan, M. L.; Chi, P.; Crago, A. M.; Maki, R. G.; Schwartz, G. K.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Progression-free survival among patients with well-differentiated or dedifferentiated liposarcoma treated with CDK4 inhibitor palbociclib: A phase 2 clinical trial
    Journal Article

    Dickson, M. A.; Schwartz, G. K.; Louise Keohan, M.; D'Angelo, S. P.; Gounder, M. M.; Chi, P.; Antonescu, C. R.; Landa, J.; Qin, L. X.; Crago, A. M.; more...
    JAMA Oncology (2016)

    Fulltext@MSK | Save